Skip to main content
HR 1220 113th Congress House Environmental Protection Administrative law and regulatory procedures Air quality Cardiovascular and respiratory health Climate change and greenhouse gases Environmental Protection Agency (EPA) Environmental regulatory procedures Health technology, devices, supplies

Asthma Inhalers Relief Act of 2013

Introduced: March 15, 2013 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 15, 2013
Referred to the Subcommittee on Energy and Power.
Mar 15, 2013
Referred to the House Committee on Energy and Commerce.
Mar 15, 2013
Introduced in House
 Plain-English summary Congressional Research Service

Asthma Inhalers Relief Act of 2013 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.

Terminates this Act on August 1, 2013.

What's happening now March 15, 2013

Referred to the Subcommittee on Energy and Power.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1